本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Vir Biotechnology, Inc.

5.50
-0.1300-2.31%
成交量:73.50萬
成交額:411.10萬
市值:7.65億
市盈率:-1.52
高:5.70
開:5.56
低:5.45
收:5.63
52周最高:14.45
52周最低:4.16
股本:1.39億
流通股本:9,455.46萬
量比:0.61
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-3.6228
每股收益(LYR):-3.8310
淨資產收益率:-49.06%
總資產收益率:-25.97%
市淨率:0.96
市盈率(LYR):-1.44

資料載入中...

2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities